Cooper Companies COO
NASDAQ COO
$53.91 -0.26 (-0.48%)
At close: Sep 11, 2026 · 4:00 PM EDT

Cooper Companies (COO) Cash from Financing Activities (2009 - 2026)

Cooper Companies (COO) posted Cash from Financing Activities of -$75.8 million for Q2 2026, up 48.75% on a QoQ basis from -$147.9 million in Q1 2026, and down 781.4% year-over-year from $11.1 million in Q2 2025.

Analysis

Cooper Companies (COO) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Cooper Companies has reported Cash from Financing Activities for 18 years, with the latest figure at -$75.8 million in Q2 2026.

  • On a quarterly basis, Cash from Financing Activities fell 781.4% year-over-year to -$75.8 million in Q2 2026; TTM through Apr 2026 was -$544.4 million, a 146.11% decrease from a year earlier, with the FY2025 full-year figure at -$425.9 million, down 1186.48% from the prior year.
  • Cash from Financing Activities was -$75.8 million for Q2 2026 at Cooper Companies, up from -$147.9 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $1.7 billion in Q1 2022, with the low at -$368.7 million in Q3 2022.
  • Average Cash from Financing Activities over 5 years is $22.7 million, with a median of -$66.4 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities surged 12552.94% in 2022, then plunged 1713.79% in 2023.
  • Over 5 years, Cash from Financing Activities stood at -$134.1 million in 2022, then jumped by 95.15% to -$6.5 million in 2023, then slumped by 336.92% to -$28.4 million in 2024, then tumbled by 478.87% to -$164.4 million in 2025, then soared by 53.89% to -$75.8 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$75.8 million (Q2 2026), -$147.9 million (Q1 2026), and -$164.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn -3.52 Bn
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn -287.90 Mn
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn -343.00 Mn
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn -95.00 Mn
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn -410.00 Mn
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn -300,000.00
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn -510.00 Mn
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn -607.30 Mn
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn -213.50 Mn
10 Cooper Companies 10.51 Bn 10.37 Bn 735.40 Mn -75.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -75.80 Mn
Jan 31, 2026 -147.90 Mn
Oct 31, 2025 -164.40 Mn
Jul 31, 2025 -156.30 Mn
Apr 30, 2025 -8.60 Mn
Jan 31, 2025 -96.60 Mn
Oct 31, 2024 -28.40 Mn
Jul 31, 2024 -87.60 Mn
Apr 30, 2024 -57.10 Mn
Jan 31, 2024 212.30 Mn
Oct 31, 2023 -6.50 Mn
Jul 31, 2023 -43.00 Mn
Apr 30, 2023 -46.80 Mn
Jan 31, 2023 -77.60 Mn
Oct 31, 2022 -134.10 Mn
Jul 31, 2022 -368.70 Mn
Apr 30, 2022 2.90 Mn
Jan 31, 2022 1.69 Bn
Oct 31, 2021 -123.80 Mn
Jul 31, 2021 -108.60 Mn